
Medical Supply International USA, Inc. MSIU
Finances
2017 | 2016 | 2005 | |
---|---|---|---|
Revenue | 2.817 M -22.61 % | 3.641 M 905.51 % | 362.071 K |
Net income | 394.840 K 6 866.13 % | 5.668 K 100.90 % | -627.334 K |
Income before tax | 394.840 K 6 866.13 % | 5.668 K 100.90 % | -627.334 K |
Income before tax ratio | 0.14 8 901.67 % | 0.00 100.09 % | -1.73 |
EBITDA | 456.060 K 1 312.08 % | 32.297 K 108.37 % | -385.726 K |
Net income ratio | 0.14 8 901.67 % | 0.00 100.09 % | -1.73 |
Ratio EBITDA | 0.16 1 724.70 % | 0.01 100.83 % | -1.07 |
Gross profit ratio | 0.62 36.62 % | 0.46 184.49 % | -0.54 |
Weighted average shs out dil | 25.506 M 0.00 % | 25.506 M 0.00 % | 25.506 M |
Weighted average shs out | 25.506 M 0.00 % | 25.506 M 0.00 % | 25.506 M |
EPS diluted | 0.02 7 650.00 % | 0.00 100.58 % | -0.03 |
Earnings per share | 0.02 7 650.00 % | 0.00 100.81 % | -0.02 |
Gross profit | 1.759 M 5.73 % | 1.663 M 949.50 % | -195.807 K |
Income tax expense | 2.000 166.67 % | -3.000 -175.00 % | 4.000 |
Cost of revenue | 1.059 M -46.46 % | 1.977 M 254.42 % | 557.878 K |
General and administrative expenses | 0.000 | 0.000 | 0.000 |
Selling and marketing expenses | 0.000 | 0.000 | 0.000 |
Other expenses | 0.000 | 0.000 | 0.000 |
Operating expenses | 1.320 M -20.12 % | 1.653 M 270.99 % | 445.566 K |
Cost and expenses | 2.379 M -34.46 % | 3.630 M 261.78 % | 1.003 M |
Research and development expenses | 0.000 | 0.000 | 0.000 |
Selling general and administrative expenses | 1.320 M -20.12 % | 1.653 M 270.99 % | 445.566 K |
Interest income | 0.000 | 0.000 | 0.000 |
Interest expense | 43.342 K 816.13 % | 4.731 K -91.65 % | 56.653 K |
Depreciation and amortization | 17.878 K -18.34 % | 21.894 K -88.16 % | 184.957 K |
Operating income | 438.180 K 4 117.32 % | 10.390 K 101.62 % | -641.370 K |
Operating income ratio | 0.16 5 349.65 % | 0.00 100.16 % | -1.77 |
Total other income expenses net | -43.342 K -817.29 % | -4.725 K -133.66 % | 14.039 K |
2017 | 2016 | 2005 |
2017 | 2016 | 2005 | |
---|---|---|---|
Net debt | 216.608 K 681.13 % | 27.730 K -97.67 % | 1.188 M |
Total investments | 0.000 | 0.000 | 0.000 |
Total debt | 227.002 K 718.62 % | 27.730 K -97.71 % | 1.209 M |
Accumulated other comprehensive income loss | 121.459 K 0.00 % | 121.459 K -86.41 % | 893.426 K |
Retained earnings | 71.696 K 112.54 % | -571.950 K 58.74 % | -1.386 M |
Common stock | 121.459 K 0.00 % | 121.459 K 1 289.53 % | 8.741 K |
Total equity | 193.155 K 142.88 % | -450.491 K 17.61 % | -546.756 K |
Other non current liabilities | 0.000 | 0.000 | 0.000 |
Long term debt | 116.054 K 318.51 % | 27.730 K -97.71 % | 1.209 M |
Total non current liabilities | 116.053 K 318.53 % | 27.729 K -97.71 % | 1.209 M |
Other current liabilities | 106.000 -99.45 % | 19.314 K -39.44 % | 31.890 K |
Deferred revenue | 26.968 K | 0.000 | 0.000 |
Short term debt | 110.948 K | 0.000 | 0.000 |
Total current liabilities | 561.562 K 6.38 % | 527.862 K -13.52 % | 610.410 K |
Total liabilities | 677.616 K 21.96 % | 555.592 K -69.47 % | 1.820 M |
Other non current assets | 8.799 K -0.01 % | 8.800 K | 0.000 |
Long term investments | 0.000 | 0.000 | 0.000 |
Intangible assets | 0.000 | 0.000 -100.00 % | 9.428 K |
GoodWill | 0.000 | 0.000 | 0.000 |
Goodwill and intangible assets | 0.000 | 0.000 -100.00 % | 9.428 K |
Property plant equipment net | 50.402 K -13.32 % | 58.150 K -95.10 % | 1.186 M |
Total non current assets | 59.201 K -11.57 % | 66.950 K -94.40 % | 1.196 M |
Other current assets | 14.871 K 68.11 % | 8.846 K 352.48 % | 1.955 K |
Short term investments | 0.000 | 0.000 | 0.000 |
cash and cash equivalents | 10.394 K | 0.000 -100.00 % | 21.429 K |
Cash and short term investments | 10.394 K | 0.000 -100.00 % | 21.429 K |
Total current assets | 811.569 K 2 027.25 % | 38.151 K -50.67 % | 77.339 K |
Inventory | 29.305 K 0.00 % | 29.305 K 400.85 % | 5.851 K |
Net receivables | 757.000 K | 0.000 -100.00 % | 48.104 K |
Tax assets | 0.000 | 0.000 | 0.000 |
Other assets | 0.000 | 0.000 | 0.000 |
Account payables | 423.540 K -16.72 % | 508.548 K -12.10 % | 578.520 K |
Tax payables | 26.968 K 32.27 % | 20.389 K | 0.000 |
Deferred revenue non current | 0.000 | 0.000 | 0.000 |
Minority interest | 0.000 | 0.000 | 0.000 |
Capital lease obligations | 0.000 | 0.000 | 0.000 |
Preferred stock | 0.000 | 0.000 | 0.000 |
Other total stockholders equity | -121.459 K 0.00 % | -121.459 K -93.24 % | -62.854 K |
Deferred tax liabilities non current | 0.000 | 0.000 | 0.000 |
Other liabilities | 0.000 | 0.000 | 0.000 |
Total assets | 870.771 K 728.51 % | 105.101 K -91.74 % | 1.273 M |
2017 | 2016 | 2005 |
2017 | 2005 | |
---|---|---|
Deferred income tax | 0.000 | 0.000 |
Stock based compensation | 0.000 | 0.000 |
Change in working capital | -840.272 K -617.11 % | 162.493 K |
Accounts receivables | -757.000 K -16 618.20 % | -4.528 K |
Inventory | 0.000 -100.00 % | 16.988 K |
Accounts payables | -85.008 K -142.02 % | 202.284 K |
Other working capital | 1.735 K 103.32 % | -52.251 K |
Other non cash items | 1.127 M | 0.000 |
Net cash provided by operating activities | -178.749 K 36.13 % | -279.884 K |
Investments in property plant and equipment | -16.652 K 93.41 % | -252.678 K |
Acquisitions net | 6.522 K | 0.000 |
Purchases of investments | 0.000 | 0.000 |
Sales maturities of investments | 0.000 | 0.000 |
Other investing activites | 0.000 | 0.000 |
Net cash used for investing activites | -10.130 K 95.99 % | -252.678 K |
Debt repayment | 0.000 -100.00 % | 341.860 K |
Common stock issued | 0.000 -100.00 % | 127.436 K |
Common stock repurchased | 0.000 | 0.000 |
Dividends paid | 0.000 | 0.000 |
Other financing activites | 199.272 K 913.33 % | 19.665 K |
Net cash used provided by financing activities | 199.272 K -59.25 % | 488.961 K |
Effect of forex changes on cash | 0.000 | 0.000 |
Net change in cash | 10.393 K 123.84 % | -43.601 K |
Cash at beginning of period | 0.000 | 0.000 |
Cash at end of period | 10.394 K 123.84 % | -43.601 K |
Operating cash flow | -178.749 K 36.13 % | -279.884 K |
Capital expenditure | -16.652 K 93.41 % | -252.678 K |
Free CashFlow | -195.401 K 63.31 % | -532.562 K |
2017 | 2005 |
Revenue |
Net income |
Income before tax |
Income before tax ratio |
EBITDA |
Net income ratio |
Ratio EBITDA |
Gross profit ratio |
Weighted average shs out dil |
Weighted average shs out |
EPS diluted |
Earnings per share |
Gross profit |
Income tax expense |
Cost of revenue |
General and administrative expenses |
Selling and marketing expenses |
Other expenses |
Operating expenses |
Cost and expenses |
Research and development expenses |
Selling general and administrative expenses |
Interest income |
Interest expense |
Depreciation and amortization |
Operating income |
Operating income ratio |
Total other income expenses net |
Net debt |
Total investments |
Total debt |
Accumulated other comprehensive income loss |
Retained earnings |
Common stock |
Total equity |
Other non current liabilities |
Long term debt |
Total non current liabilities |
Other current liabilities |
Deferred revenue |
Short term debt |
Total current liabilities |
Total liabilities |
Other non current assets |
Long term investments |
Intangible assets |
GoodWill |
Goodwill and intangible assets |
Property plant equipment net |
Total non current assets |
Other current assets |
Short term investments |
cash and cash equivalents |
Cash and short term investments |
Total current assets |
Inventory |
Net receivables |
Tax assets |
Other assets |
Account payables |
Tax payables |
Deferred revenue non current |
Minority interest |
Capital lease obligations |
Preferred stock |
Other total stockholders equity |
Deferred tax liabilities non current |
Other liabilities |
Total assets |
Deferred income tax |
Stock based compensation |
Change in working capital |
Accounts receivables |
Inventory |
Accounts payables |
Other working capital |
Other non cash items |
Net cash provided by operating activities |
Investments in property plant and equipment |
Acquisitions net |
Purchases of investments |
Sales maturities of investments |
Other investing activites |
Net cash used for investing activites |
Debt repayment |
Common stock issued |
Common stock repurchased |
Dividends paid |
Other financing activites |
Net cash used provided by financing activities |
Effect of forex changes on cash |
Net change in cash |
Cash at beginning of period |
Cash at end of period |
Operating cash flow |
Capital expenditure |
Free CashFlow |